Harvard Bioscience, Inc.
HBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $4 | $5 | $8 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $15 | $16 | $17 | $22 |
| Inventory | $23 | $25 | $26 | $28 |
| Other Curr. Assets | $3 | $4 | $3 | $4 |
| Total Curr. Assets | $45 | $49 | $51 | $62 |
| Property Plant & Equip (Net) | $11 | $9 | $9 | $10 |
| Goodwill | $56 | $57 | $56 | $58 |
| Intangibles | $11 | $16 | $21 | $27 |
| Long-Term Investments | $0 | $4 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $3 | $8 | $5 |
| Total NC Assets | $82 | $88 | $94 | $101 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $127 | $137 | $145 | $162 |
| Liabilities | – | – | – | – |
| Payables | $5 | $6 | $6 | $5 |
| Short-Term Debt | $38 | $7 | $6 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $4 | $0 | $3 | $4 |
| Other Curr. Liab. | $8 | $14 | $7 | $11 |
| Total Curr. Liab. | $55 | $27 | $23 | $25 |
| LT Debt | $6 | $35 | $48 | $52 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $1 | $1 | $1 | $2 |
| Other NC Liab. | $1 | $1 | $1 | $0 |
| Total NC Liab. | $8 | $38 | $50 | $54 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $8 | $6 | $7 | $9 |
| Total Liabilities | $63 | $64 | $73 | $79 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$158 | -$146 | -$142 | -$133 |
| AOCI | -$16 | -$14 | -$15 | -$10 |
| Other Equity | $237 | $232 | $229 | $226 |
| Total Equity | $63 | $73 | $72 | $83 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $127 | $137 | $145 | $162 |
| Net Debt | $40 | $38 | $50 | $49 |